UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Advanced drug delivery reviews, ISSN 0169-409X, 2002, Volume 54, Issue 5, pp. 695 - 713
Anticancer drugs | Drug targeting | Poly( l-glutamic acid) | Polymer–drug conjugates | Enhanced permeability and retention effect | Poly(L-glutamic acid) | Polymer-drug conjugates | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Camptothecin - therapeutic use | Humans | Antineoplastic Agents - therapeutic use | Clinical Trials as Topic | Antineoplastic Agents - administration & dosage | DNA - metabolism | Antimetabolites - therapeutic use | Paclitaxel - therapeutic use | Polyglutamic Acid - chemical synthesis | Drug Carriers | Drug Delivery Systems | Neoplasms - drug therapy | Antimetabolites - administration & dosage | Antineoplastic Agents - metabolism | Polyglutamic Acid - pharmacokinetics | Anthracyclines - administration & dosage | Camptothecin - administration & dosage | Anthracyclines - therapeutic use | Paclitaxel - administration & dosage | Index Medicus
Journal Article
Molecules (Basel, Switzerland), ISSN 1420-3049, 10/2018, Volume 23, Issue 10, p. 2565
Chitosan | PGA | Immunogenicity | Adenovirus | Biodegradable polymer | Biochemistry & Molecular Biology | Physical Sciences | Chemistry | Life Sciences & Biomedicine | Chemistry, Multidisciplinary | Science & Technology | Drug Carriers - therapeutic use | Nanoparticles - chemistry | Humans | Drug Carriers - chemistry | Polyglutamic Acid - analogs & derivatives | Polymers - therapeutic use | Antibodies, Neutralizing - immunology | Neoplasms - therapy | Immunity, Cellular - drug effects | Nanoparticles - therapeutic use | Chitosan - therapeutic use | Adenoviridae - genetics | Adenoviridae - immunology | Oncolytic Virotherapy - adverse effects | Chitosan - immunology | Oncolytic Viruses - genetics | Polyglutamic Acid - immunology | Antibodies, Neutralizing - drug effects | Polyglutamic Acid - chemistry | Chitosan - chemistry | Neoplasms - immunology | Oncolytic Viruses - immunology | Ligands | Polymers - chemistry | Polyglutamic Acid - therapeutic use | Index Medicus | chitosan | biodegradable polymer | γ-PGA | immunogenicity | adenovirus
Journal Article
Nanomedicine, ISSN 1549-9634, 2012, Volume 8, Issue 1, pp. 71 - 80
Internal Medicine | Hyaluronan | Ehrlich ascites tumor (EAT) | Antitumor activity | Doxorubicin | Polymersomes | Science & Technology - Other Topics | Nanoscience & Nanotechnology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Doxorubicin - blood | Doxorubicin - therapeutic use | Drug Carriers - adverse effects | Hyaluronic Acid - therapeutic use | Nanoparticles - chemistry | Antineoplastic Agents - chemical synthesis | Humans | Drug Carriers - administration & dosage | Polyglutamic Acid - administration & dosage | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Nanoparticles - adverse effects | Drug Carriers - chemistry | Polyglutamic Acid - analogs & derivatives | Antineoplastic Agents - adverse effects | Female | Hyaluronic Acid - blood | Hyaluronic Acid - adverse effects | Doxorubicin - administration & dosage | Endocytosis - immunology | Technetium - chemistry | Rabbits | Hyaluronic Acid - administration & dosage | Hyaluronic Acid - chemistry | Carcinoma, Ehrlich Tumor - drug therapy | Doxorubicin - chemical synthesis | Polyglutamic Acid - blood | Polyglutamic Acid - chemistry | Animals | Hyaluronic Acid - analogs & derivatives | Antineoplastic Agents - blood | Hyaluronan Receptors - immunology | Mice | Mice, Inbred BALB C | Nanoparticles - administration & dosage | Polyglutamic Acid - therapeutic use | Neoplasms, Experimental - drug therapy | Doxorubicin - adverse effects | Polyglutamic Acid - adverse effects | Anthracyclines | Ascites | Hyaluronic acid | Tumors | Index Medicus | Polymers | Chemical Sciences
Journal Article
Biomaterials, ISSN 0142-9612, 2011, Volume 32, Issue 15, pp. 3862 - 3874
Advanced Basic Science | Dentistry | Angiogenesis | Integrin | Polyglutamic acid | Polymer therapeutics | Paclitaxel | RGD peptidomimetic | Engineering | Materials Science | Technology | Engineering, Biomedical | Materials Science, Biomaterials | Science & Technology | Paclitaxel - metabolism | Rats, Wistar | Humans | Polyglutamic Acid - administration & dosage | Integrins - metabolism | Drug Delivery Systems | Polyglutamic Acid - analogs & derivatives | Paclitaxel - chemistry | Antineoplastic Agents, Phytogenic - administration & dosage | Antineoplastic Agents, Phytogenic - metabolism | Antineoplastic Agents, Phytogenic - therapeutic use | Paclitaxel - administration & dosage | Oligopeptides - chemistry | Polyglutamic Acid - metabolism | Paclitaxel - analogs & derivatives | Rats | Antineoplastic Agents, Phytogenic - chemistry | Cathepsin B - metabolism | Oligopeptides - metabolism | Paclitaxel - therapeutic use | Neoplasms - drug therapy | Polyglutamic Acid - chemistry | Animals | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Mice, Inbred BALB C | Polyglutamic Acid - therapeutic use | Drugs | Drug delivery systems | Biological products | Endothelial growth factors | Development and progression | Permeability | Antineoplastic agents | Cells | Endothelium | Vehicles | Antimitotic agents | Fibrin | Fibrinogen | Physiological aspects | Polymer industry | Polymers | Vascular endothelial growth factor | Tumors | Integrins | Index Medicus | paclitaxel | polymer therapeutics | integrin
Journal Article
Nature biotechnology, ISSN 1087-0156, 04/2016, Volume 34, Issue 4, pp. 414 - 418
Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Science & Technology | Doxorubicin - therapeutic use | Humans | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Doxorubicin - pharmacokinetics | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Animals | Mice, Nude | Nanoparticles - therapeutic use | Nanomedicine - methods | Cell Line, Tumor | Female | Polyglutamic Acid | Antineoplastic Agents - pharmacokinetics | Mice | Nanoparticles - administration & dosage | Drug Delivery Systems - methods | Doxorubicin - administration & dosage | Nanoparticles | Cancer therapies | Tumors | Cancer | Index Medicus
Journal Article
Acta biomaterialia, ISSN 1742-7061, 11/2016, Volume 45, pp. 223 - 233
Hyaluronic acid | Polypeptide | Nanomedicine | Cancer therapy | Redox-responsive | Engineering | Materials Science | Technology | Engineering, Biomedical | Materials Science, Biomaterials | Science & Technology | Doxorubicin - therapeutic use | Nanoparticles - chemistry | Biocompatible Materials - chemistry | Humans | Antineoplastic Agents - therapeutic use | Polyethylene Glycols - therapeutic use | Polyglutamic Acid - analogs & derivatives | Peptides - chemical synthesis | MCF-7 Cells | Proton Magnetic Resonance Spectroscopy | Doxorubicin - analogs & derivatives | Female | Antineoplastic Agents - pharmacology | Thioctic Acid - chemistry | Polyethylene Glycols - pharmacology | Tissue Distribution - drug effects | Cross-Linking Reagents - chemistry | Hyaluronic Acid - chemistry | Polyethylene Glycols - pharmacokinetics | Thioctic Acid - chemical synthesis | Breast Neoplasms - drug therapy | Polyglutamic Acid - chemical synthesis | Doxorubicin - pharmacokinetics | Xenograft Model Antitumor Assays | Polyglutamic Acid - chemistry | Animals | Breast Neoplasms - pathology | Mice, Nude | Drug Liberation | Doxorubicin - pharmacology | Care and treatment | Cancer | Tumors | Crosslinked polymers | Anthracyclines | Chemotherapy | Physiological aspects | Glutamate | Doxorubicin | Self assembly | Glutamic acid | Lipoic acid | Xenotransplantation | Breast cancer | Cancer therapies | Mimicry | Lipopolysaccharides | Anticancer properties | Nanoparticles | Acids | CD44 antigen | Xenografts | Antitumor activity | Mice | In vivo methods and tests | Index Medicus | Drugs | Breast | Nanostructure
Journal Article
Journal of biomedical materials research. Part A, ISSN 1549-3296, 11/2017, Volume 105, Issue 11, pp. 3006 - 3016
poly(L‐glutamic acid) | intra‐articular injection | hyaluronan | cartilage | intra-articular injection | poly(L-glutamic acid) | Engineering | Materials Science | Technology | Engineering, Biomedical | Materials Science, Biomaterials | Science & Technology | Viscosity | Hyaluronic Acid - therapeutic use | Hyaluronic Acid - administration & dosage | Chondrocytes - immunology | Cells, Cultured | Hyaluronic Acid - chemistry | Elasticity | Male | Polyglutamic Acid - administration & dosage | Rats, Sprague-Dawley | Chondrocytes - drug effects | Polyglutamic Acid - chemistry | Animals | Anti-Inflammatory Agents - chemistry | Injections, Intra-Articular | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Osteoarthritis, Knee - immunology | Polyglutamic Acid - therapeutic use | Osteoarthritis, Knee - drug therapy | Glutamate | Hyaluronic acid | Amino acids | Viscoelasticity | Knee | Glutamic acid | Storage modulus | Dendritic cells | Syngeneic grafts | Durability | Inflammation | Loss modulus | Injection | Grafting | Anti-inflammatory agents | Biological activity | Medicine | Hyaluronan | Biomedical materials | Acids | Immunogenicity | Chondrocytes | Interleukin 1 | Bone marrow | Biocompatibility | Osteoarthritis | Index Medicus
Journal Article
ACS applied materials & interfaces, ISSN 1944-8244, 03/2013, Volume 5, Issue 5, pp. 1781 - 1792
electrostatic interaction | antitumor | doxorubicin hydrochloride | nonsmall cell lung cancer | pH-responsive | poly(l -glutamic acid) | Science & Technology - Other Topics | Materials Science | Nanoscience & Nanotechnology | Technology | Materials Science, Multidisciplinary | Science & Technology | Doxorubicin - therapeutic use | Drug Delivery Systems - instrumentation | Antineoplastic Combined Chemotherapy Protocols - chemistry | Humans | Rats | Male | Doxorubicin - chemistry | Rats, Sprague-Dawley | Drug Carriers - chemistry | Polyglutamic Acid - chemistry | Animals | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Mice | Mice, Inbred BALB C | Surface-Active Agents - chemistry | Carcinoma, Non-Small-Cell Lung - drug therapy | Drug Delivery Systems - methods | Index Medicus
Journal Article
Molecular imaging, ISSN 1535-3508, 1/2011, Volume 10, Issue 1, pp. 28 - 42
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Radiology, Nuclear Medicine & Medical Imaging | Biochemical Research Methods | Science & Technology | Polyglutamic Acid - analogs & derivatives | Polyglutamic Acid - chemistry | Humans | Neoplasms - radiotherapy | Antineoplastic Agents - therapeutic use | Neoplasms - diagnosis | Antineoplastic Agents - chemistry | Drug Delivery Systems - methods | Neoplasms - drug therapy | Index Medicus | macromolecular contrast agents | Poly(L-glutamic acid) | polymers | PG-paclitaxel | anticancer drugs
Journal Article